Alpine Global Management’s Clover Health Investments CLOV Stock Holding History

Alpine Global Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-71,856	Closed	-$226K	–	150
2024 Q4	$226K	Buy	+71,856	New	+$257K	0.07%	116
2023 Q1	–	Sell	-123,982	Closed	-$115K	–	208
2022 Q4	$115K	Buy	123,982 +107,194	+639%	+$143K	0.04%	203
2022 Q3	$29K	Sell	16,788 -45,887	-73%	-$120K	0.01%	157
2022 Q2	$134K	Buy	62,675 +7,481	+14%	+$19.9K	0.03%	138
2022 Q1	$196K	Sell	55,194 -218,635	-80%	-$634K	0.04%	251
2021 Q4	$1.02M	Buy	+273,829	New	+$1.68M	0.15%	145
2021 Q1	–	Sell	-30,360	Closed	-$509K	–	325
2020 Q4	$509K	Buy	+30,360	New	+$338K	0.1%	102

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Alpine Global Management's CLOV Position: Q1 2025 in Review

Alpine Global Management sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 71,856 shares — an estimated $226K sold.

Alpine Global Management first reported a position in CLOV in Q4 2020 and held it in 7 quarters. The position peaked at $1.02M in Q4 2021. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

Alpine Global Management reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
Alpine Global Management sold 71,856 Clover Health Investments shares in Q1 2025, an estimated $226K.
Alpine Global Management first reported a position in Clover Health Investments in Q4 2020 and held it in 7 quarters.
Alpine Global Management's Clover Health Investments position peaked at $1.02M in Q4 2021.
202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.